RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sanara Medtech Stock

Sanara Medtech Stocks 2024

Sanara Medtech Stocks

8.28 M

Ticker

SMTI

ISIN

US79957L1008

In 2024, Sanara Medtech had 8.28 M outstanding stocks, a 0% change from the 8.28 M stocks in the previous year.

The Sanara Medtech Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2025e8.28
2024e8.28
20238.28
20227.91
20217.34
20205.73
20192.13
20182.17
20172.09
20161.09
20151.07
20140.88
20130.78
20120.63
20110.55
20100.36
20090.29
20080.22
20070.16

Sanara Medtech shares outstanding

The number of shares was Sanara Medtech in 2023 — This indicates how many shares 8.279 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sanara Medtech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sanara Medtech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sanara Medtech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sanara Medtech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sanara Medtech Aktienanalyse

What does Sanara Medtech do?

Sanara Medtech Inc is a leading company specializing in the development of innovative medical devices and solutions. The company is headquartered in Texas, USA and has experienced significant growth since its founding in 2014. Its areas of specialization include wound care, incontinence management, and dermatology. The history of Sanara Medtech Inc began in 2014 when a team of experienced medical technology experts founded the company. Leveraging their extensive industry knowledge and expertise, the team quickly identified a market niche and established themselves as a leading provider of innovative solutions. The business model of Sanara Medtech Inc is focused on developing medical devices and solutions that aim to improve the daily lives of patients and healthcare professionals. The company is committed to developing and manufacturing top-quality products that contribute to enhancing patient care and supporting healthcare professionals in their tasks. Sanara Medtech Inc offers a wide range of products tailored to the needs of patients and medical professionals. Its wound care products include wound dressings, wound healing ointments, and other specialized products for treating chronic and acute wounds. The incontinence management products include disposable and reusable incontinence products designed to improve the lives of individuals with incontinence issues. Dermatology products encompass a wide range of products for treating skin conditions such as psoriasis, eczema, and rosacea, to name a few. Another focus of Sanara Medtech Inc is collaborating with private and public healthcare facilities to ensure the availability of its products in hospitals, clinics, nursing homes, and other healthcare facilities. The company also offers training and educational programs for healthcare professionals to ensure proper product use. In summary, Sanara Medtech Inc is an innovative company specializing in the development of medical devices and solutions tailored to the needs of patients and healthcare professionals. Its goal is to develop top-quality products that contribute to the improvement of healthcare and enhance the lives of patients. With a wide range of products and a strong market presence, Sanara Medtech Inc is a leading force in the medical technology industry. Sanara Medtech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Sanara Medtech's Shares Outstanding

Sanara Medtech's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Sanara Medtech’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Sanara Medtech’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Sanara Medtech’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Sanara Medtech stock

How many stocks are there of Sanara Medtech?

The current number of stocks of Sanara Medtech is 8.28 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Sanara Medtech are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Sanara Medtech evolved in recent years?

The number of shares of Sanara Medtech has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Sanara Medtech as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Sanara Medtech?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Sanara Medtech pay?

Over the past 12 months, Sanara Medtech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sanara Medtech is expected to pay a dividend of 0 USD.

What is the dividend yield of Sanara Medtech?

The current dividend yield of Sanara Medtech is .

When does Sanara Medtech pay dividends?

Sanara Medtech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sanara Medtech?

Sanara Medtech paid dividends every year for the past 0 years.

What is the dividend of Sanara Medtech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sanara Medtech located?

Sanara Medtech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sanara Medtech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sanara Medtech from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Sanara Medtech pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Sanara Medtech in the year 2023?

In the year 2023, Sanara Medtech distributed 0 USD as dividends.

In which currency does Sanara Medtech pay out the dividend?

The dividends of Sanara Medtech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sanara Medtech

Our stock analysis for Sanara Medtech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sanara Medtech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.